Application 208569

Type
ANDA
Sponsor
TEVA PHARMS USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TERIPARATIDETERIPARATIDESOLUTION;SUBCUTANEOUS0.56MG/2.24ML (0.25MG/ML)NoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
76798ORIG 2023-12-14